Mother gives dramatic account of baby born with addiction to opioids

Possession of Pharmaceuticals in New Orleans

View Video and article HERE – THE HILL ARTICLE ARTICLE WRITTEN BY “JULIA MANCHESTER” source – TheHill.com The U.S. Judicial Panel on Multidistrict Litigation (JPML) earlier this month denied a request from the Opioid Justice Team to create a new multidistrict litigation proceeding for babies born addicted to opioids, also known as Neo-natal Abstinence Syndrome (NAS).  The…


Louisiana Split-Jury Rule Abolished in November Election

Picture of vote stickers

Last month, Louisiana voters amended Article 1, Section 17 of the Louisiana Constitution when they voted to abolish the split-jury rule. Prior to the election, Louisiana was one of two states that did not require a unanimous jury verdict in noncapital criminal cases. The split-jury rule only requires 10 of 12 jurors in a 12-person…


Drugmakers Oppose Separate Opioid Case for Addicted Children

Narcotics Possession in New Orleans

source : Bloomberg News Companies making and distributing opioid painkillers opposed a proposal to separate lawsuits filed on behalf of addicted babies from local governments’ cases aimed at recouping costs of battling the public-health crisis spawned by the drugs. Attorneys for thousands of babies born to opioid addicts asked a panel of federal judges Thursday…


Lawyers for Opioid-Addicted Babies Push For Separate Legal Proceedings

Possession of Pharmaceuticals in New Orleans

Bloomberg Law News Sep 21, 2018 Lawyers for Opioid-Addicted Babies Push For Separate Legal Proceedings By Julie Steinberg Sep 21, 2018 • Concerns include that potential settlements won’t provide sufficient medical monitoring, treatment funds • Attorneys for government-entity plaintiffs, defendant drugmakers, distributors in massive consolidated litigation have opposed separate track Attorneys representing potentially thousands of…


Is Price Gouging Common in the Pharmacy Industry?

Narcotics Possession in New Orleans

A pharmacy company has come under fire after a long-standing cancer medication’s price increased by 1,500 percent in the last four years. The drug, originally known as CeeNU, has no generic alternative and was originally priced at $50 a pill. The price increase comes after a change in ownership. The original owner sold the medication…


© 2019 Martzell, Bickford & Centola. All Rights Reserved. | Sitemap | Developed By MediaSmack